Cancer Metabolism | Home page

Time 2020-11-06 15:06:39

Web Name: Cancer Metabolism | Home page

WebSite: http://cancerandmetabolism.biomedcentral.com

ID:106949

Keywords:

Metabolism,Cancer,page,Cancer&Metabolism,CancerResearch,Oncology,Metabolomic

Description:

We are delighted to announceCancer Metabolism'sfirst Impact Factor is5.033!Thank youto our Editors-in-Chief Dr. Michael Pollak and Dr. Matthew G. Vander Heiden for their hard work and to all those who support this journal.The current EigenfactorScore is 0.33812 and the Immediacy Index is0.583. Cancer Metabolism welcomes studies on all aspects of the relationship between cancer including molecular biology and genetics. The journal is indexed in DOAJ, Emerging Sources Citation Index (ESCI), PubMed, and PubMed Central.Learn more Dr. MichaelPollak, co-Editor-in-ChiefDr. Pollak is an internationally recognized expert in cancer endocrinology at the Lady Davis Institute for Medical Research of McGill University and a clinical oncologist at the Jewish General Hospital, Quebec, Canada."Cancer Metabolism will provide a forum for rapid dissemination of research findings concerning metabolic factors that influence cancer risk and cancer pathophysiology, and cancer treatment. The scope of the Journal will allow for an interdisciplinary readership including cancer biologists, endocrinologists, oncologists, clinical trialists and population scientists." Dr. Matthew G. Vander Heiden, co-Editor-in-ChiefDr. Vander Heiden is Associate Director at the Koch Institute for Integrative Cancer Research at MIT. Extensively published in over 140 peer reviewed articles and book chapters, his research interests focus on the metabolic processes of cancer cells, including how glucose metabolism affects tumor growth and how these studies may lead to new developments in targeted cancer therapy. A renowned innovative researcher in his field, Dr. Vander Heiden received the 2017 Philip A. Sharp Innovation in Collaboration Award from Stand Up to Cancer (SU2C). Associate Editors:Kevin Brindle,University of Cambridge, UKNavdeep Chandel,Northwestern University, USAEyal Gottlieb,Beatson Institute for Cancer Research, UKEditorial Board Members:Abass Alavi,University of Pennsylvania School of Medicine, USALewis Cantley,Weill Cornell Medical College, USAPeter Carmeliet,Vesalius Research Center, BelgiumTeresa Fan,Markey Cancer Center, USARobert Gatenby,H. Lee Moffitt Cancer Center and Research Institute, USAKun-Liang Guan,University ofCalifornia,San Diego, USARudolf Kaaks,German Cancer Research Center, GermanyAndrew Lane,Markey Cancer Center, USAGordon Mills,University of Texas M. D. Anderson Cancer Center, USAJacques Pouyssegur,Institute of Research on Cancer and Aging, France Joshua Rabinowitz,Princeton University, USAPeter Ratcliffe,Nuffield Department of Clinical Medicine, UKJeffrey Rathmell, Duke University, USAJared Rutter,University of Utah School of Medicine, USADavid Sabatini,Whitehead Institute for Biomedical Research, USAPaolo Sassone-Corsi,Universityof California,Irvine, USAGregg Semenza,Johns Hopkins University School of Medicine, USACeleste Simon,University of Pennsylvania School of Medicine, USAAlexei Vazquez,The Cancer Institute of New Jersey, USABert Vogelstein,Johns Hopkins University School of Medicine, USAKaren Vousden,Beatson Institute for Cancer Research, UKKathryn Wellen,University of Pennsylvania, USAEileen White,The Cancer Institute of New Jersey, USAYue Xiong,University of North Carolina, Chapel Hill, USA Authors: Victor Ruiz-Rodado, Adrian Lita, Tyrone Dowdy, Orieta Celiku, Alejandra Cavazos Saldana, Herui Wang, Chun Zhang Yang, Raj Chari, Aiguo Li, Wei Zhang, Hua Song, Meili Zhang, Susie Ahn, Dionne Davis, Xiang Chen, Zhengping Zhuang Content type: Research 21 October 2020 Authors: Daniela Gaglio, Marcella Bonanomi, Silvia Valtorta, Rohit Bharat, Marilena Ripamonti, Federica Conte, Giulia Fiscon, Nicole Righi, Elisabetta Napodano, Federico Papa, Isabella Raccagni, Seth J. Parker, Ingrid Cifola, Tania Camboni, Paola Paci, Anna Maria Colangelo Content type: Research 29 September 2020 Authors: Chao Hu, Xiong Chen, Chengyun Yao, Yu Liu, Haojun Xu, Guoren Zhou, Hongping Xia and Jinglin Xia Content type: Research 25 September 2020 Authors: Jacqueline Tait-Mulder, Kelly Hodge, David Sumpton, Sara Zanivan and Alexei Vazquez Content type: Research 21 September 2020 Authors: Stephen D Hursting, Sarah M Dunlap, Nikki A Ford, Marcie J Hursting and Laura M Lashinger Content type: Review 7 March 2013 Authors: Julia Billiard, Jennifer B Dennison, Jacques Briand, Roland S Annan, Deping Chai, Mariela Col贸n, Christopher S Dodson, Seth A Gilbert, Joel Greshock, Junping Jing, Hong Lu, Jeanelle E McSurdy-Freed, Lisa A Orband-Miller, Gordon B Mills, Chad J Quinn, Jessica L Schneck Content type: Research 6 September 2013 Authors: Sylvia Andrzejewski, Simon-Pierre Gravel, Michael Pollak and Julie St-Pierre Content type: Research 28 August 2014 The biology of tumor cells in breast cancer is complex and relatively unexplored. Cancer Metabolism is excited to present the following article highlights that identify novel biomarkers and metabolic profiles of different breast cancer subtypes.-Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities-Metabolomics of oncogene-specific metabolic reprogramming during breast cancer-Beta-hydroxybutyrate (3-OHB) can influence the energetic phenotype of breast cancer cells, but does not impact their proliferation and the response to chemotherapy or radiation-Activation of pro-survival metabolic networks by 1,25(OH)2D3 does not hamper the sensitivity of breast cancer cells to chemotherapeutics-The novel function of tumor protein D54 in regulating pyruvate dehydrogenase and metformin cytotoxicity in breast cancer Chi Van Dang,Editor EmeritusChi Dang is a professor, physician-researcher, renowned cancer biologist and hematologist-oncologist, who serves as director of the Abramson Cancer Center at the University of Pennsylvania."After several decades of profound advances in our understanding of the genetics and molecular biology of cancer, it has become self-evident that metabolism and bioenergetics are regulated by cancer genes and are intimately linked to the growth and survival of cancer cells. The obesity pandemic connected to increased cancer risk further underscore the importance of a richer understanding of cancer and organismal metabolism. In this regard, Cancer Metabolism is launched uniquely to fulfill the needs of a burgeoning field which is at the crossroads of many scientific disciplines." As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our usual peer review process.We thank referees for their continued support in these challenging times and ask authors for their patience and understanding.Thumbnail imageby Felipe Esquivel Reed, used under Creative Commons Attribution-Share Alike 4.0 license. Speed65 days to first decision for reviewed manuscripts only59 days to first decision for all manuscripts135 days from submission to acceptance35 days from acceptance to publicationCitation Impact5.033 -2 Year Impact Factor0.583 - Immediacy IndexUsage140,853 Downloads210 Altmetric Mentions

TAGS:Metabolism Cancer page Cancer&Metabolism CancerResearch Oncology Metabol

<<< Thank you for your visit >>>

Cancer &amp; Metabolism is proud to have leading experts who drive research in this niche field on its Editorial Board, reviewing manuscripts for quality, rather ...

Hot Websites